Oasis, The Online Abstract Submission System

8 downloads 1572 Views 96KB Size Report
Nov 15, 2010 - For all log-in problems or technical questions, please contact OASIS Helpdesk or call (217) 398-1792. If you have any policy questions related ...
15/11/2010

Print this Page for Your Records

Oasis, The Online Abstract Submission …

Close Window

Control/Tracking Number: 11-A-1942-AACR Activity: Abstract Submission Current Date/Time: 11/15/2010 11:19:57 AM Beta adrenergic action on human breast cancer cell lines Short Title: Adrenoceptors and Human BrCa Author Block: Cecilia Pérez Piñero, Lilian F. Castillo, Ariana Bruzzone, Isabel A. Lüthy. IByME, Buenos Aires, Argentina Abstract: Breast cancer, the most frequent cancer among women in the majority of countries, is also a stressful disease. The principal effectors of the stress system include the epinephrine (EPI) and norepinephrine which bind to α 1-, α 2- and βadrenoceptors (AR). We have described α 2-AR in human tumor and non-tumor breast cell lines, associated with increased cell proliferation and tumor growth. We have also studied the effect of β-AR agonists and antagonists in different breast cancer experimental models. When animals were treated with the agonist isoproterenol (ISO) and/or salbutamol (SALB), tumor growth was significantly reduced correlating with Erk 1/2 phosphorylation status in whole protein tumor samples by Western blotting. The aims of the present work were: to assess the expression of β2-AR in human breast cancer cell lines (IBH-4, IBH-6, MDA-MB-231, MCF-7, among others) by RT-PCR and immunofluorescence (IF) techniques; to study the biological effect of β-AR agonists by means of proliferation assays and compare these results with the effect of the natural agonist (EPI); to find out the signaling pathways involved in reduced Erk phosphorylation induced by β-AR stimulation. β2-AR expression was detected by RT-PCR, using GAPDH as a control. A positive staining was seen in all cells by IF. After the incubation of the cells with increasing doses (from 10-13M to 10-6M) of the β-AR agonist (ISO or SALB), a significant reduction in [ 3H]-thymidine incorporation to the cells nuclei was observed as compared to control values (expressed as percentage of control incorporation). IBH-4: ISO 0.1μM, 75.87±8.49% vs control 100±7.18% p